Submit Content
Get the latest delivered to your inbox
Privacy Policy

Johnson & Johnson

Caring for the world, one person at a time... inspires and unites the people of Johnson & Johnson. This year, we celebrate 126 years of embracing research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work in more than 250 operating companies in 60 countries throughout the world. The passion and commitment of our people yield innovations that further minimize our impact on the planet, drive new alliances to address major health challenges in developing and developed countries, and help to create economic opportunity for people. Improving human health and well-being is our crucial mission and the ultimate measure of upholding our responsibility now and for generations to come.

At Johnson & Johnson, our top priority is health-health of people and the planet. That's why we set aggressive corporate wide goals to reduce our environmental impact, outlined in our Healthy Future 2015 goals. To this end, we established the proprietary Earthwards® process for developing and marketing greener products through lifecycle analysis. Every Earthwards® recognized product must achieve a greater than 10 percent improvement in at least three of the seven goal areas:

  • Materials used
  • Packaging reduction
  • Energy reduction
  • Waste reduction
  • Water reduction
  • Positive social impact or benefit
  • Product innovation

    Our Integrated Approach to Health (of People and Our Planet) Image

    POSTED 

    09-15-20

    Our Integrated Approach to Health (of People and Our Planet)

    Human health is complex.
    Johnson & Johnson Signs a Historic Pledge to Uphold the Integrity of the Scientific Process in Developing an Investigational COVID-19 Vaccine Image

    POSTED 

    09-14-20

    Johnson & Johnson Signs a Historic Pledge to Uphold the Integrity of the Scientific Process in Developing an Investigational COVID-19 Vaccine

    Recently, Johnson & Johnson announced that we, alongside eight other companies working on investigational COVID-19 vaccines, are signing a #WeStandWithScience pledge committed to upholding the integrity of the scientific process as we work towards potential global regulatory filings and approval...
    The Road to a Vaccine, Season 2, Ep. 5: What Have We Learned After Eight Months of COVID-19? Image

    POSTED 

    09-11-20

    The Road to a Vaccine, Season 2, Ep. 5: What Have We Learned After Eight Months of COVID-19?

    In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
    4 Innovative Ways Johnson & Johnson Has Helped Protect the Public's Health During Outbreaks Since the Late 1800s Image

    POSTED 

    09-04-20

    4 Innovative Ways Johnson & Johnson Has Helped Protect the Public's Health During Outbreaks Since the Late 1800s

    As you read this, Johnson & Johnson researchers are working around the clock in the ongoing battle against COVID-19, reviewing existing compounds that might prove useful as treatments and preparing to put an investigational vaccine candidate into clinical trials, among many other initiatives.
    Johnson & Johnson Named to Fast Company's 2020 Best Workplaces for Innovators List Image

    POSTED 

    08-17-20

    Johnson & Johnson Named to Fast Company's 2020 Best Workplaces for Innovators List

    Innovation is a key to success in business. And it's been an especially important asset during the COVID-19 pandemic, which has challenged companies large and small to find new ways of innovating.
    Johnson & Johnson Earns the #3 Spot on the 2020 Gartner Supply Chain Top 25 List Image

    POSTED 

    08-12-20

    Johnson & Johnson Earns the #3 Spot on the 2020 Gartner Supply Chain Top 25 List

    The company received its highest-ever ranking on the list this year—which honors global supply chain excellence—in part for its nimble response to the COVID-19 pandemic.
    6 Top Questions About COVID-19: What a Child Psychiatrist Has to Say Image

    POSTED 

    08-11-20

    6 Top Questions About COVID-19: What a Child Psychiatrist Has to Say

    On the latest episode of "The Road to a Vaccine," host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
    "We Have a Health Disparities Problem in America": Meet a Woman on a Mission to Improve Healthcare for Black Women Image

    POSTED 

    08-07-20

    "We Have a Health Disparities Problem in America": Meet a Woman on a Mission to Improve Healthcare for Black Women

    The U.S. has one of the highest maternal mortality rates in the developed world, with women of color especially at risk. Dr. Robyn R. Jones, Senior Medical Director at Johnson & Johnson, is determined to change that and find ways to address this urgent crisis.
    Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study Image

    POSTED 

    07-28-20

    Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study

    Since the start of the pandemic, Johnson & Johnson has been working to help address the devastating impacts of COVID-19 through the power of its science, the size of its global reach—and the know-how that comes from such experiences as standing up to challenges like HIV.
    "I Was Working on a Potential COVID-19 Vaccine-Then My Wife Got Sick": Meet a Researcher Whose Personal Experience Is Fueling His Fight Against the Pandemic Image

    POSTED 

    07-23-20

    "I Was Working on a Potential COVID-19 Vaccine-Then My Wife Got Sick": Meet a Researcher Whose Personal Experience Is Fueling His Fight Against the Pandemic

    In late January—weeks before many people had even heard of the novel coronavirus—Ramon Polo, PharmD, Ph.D., started to work on finding solutions to fight the virus, which data suggested had the potential to become a global pandemic.
    Johnson & Johnson Logo

    Johnson & Johnson

    Johnson & Johnson

    Join today and get the latest delivered to your inbox